Medicine and Dentistry
Pseudomonas aeruginosa
100%
Cystic Fibrosis
63%
Tea Tree Oil
57%
Antiinfective Agent
55%
Essential Oil
48%
Imipenem
34%
Chlorhexidine
32%
Tazobactam
27%
Tobramycin
24%
Combination Therapy
22%
Penicillinase
20%
Colistin
18%
Aztreonam
18%
Bacterial Infection
16%
β-Lactam antibiotic
13%
Lactam
13%
In Vitro
13%
Antibiotics
12%
Antibacterial Activity
9%
Staphylococcus Aureus
8%
Antimicrobial Activity
8%
Antibiotic Resistance
6%
Monotherapy
6%
Ceftazidime
6%
Patient with Cystic Fibrosis
6%
Piperacillin/Tazobactam
6%
Carbapenem Derivative
6%
Therapeutic Agent
6%
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas aeruginosa
100%
Cystic Fibrosis
63%
Tea Tree Oil
57%
Antiinfective Agent
55%
Chlorhexidine
32%
Essential Oil
28%
Tazobactam
27%
Ceftolozane
27%
Tobramycin
24%
Combination Therapy
22%
Penicillinase
20%
Minimum Inhibitory Concentration
18%
Aztreonam
18%
Colistin
18%
Bacterial Infection
16%
Organisms
16%
Beta Lactam Antibiotic
13%
Lactam
13%
Staphylococcus Aureus
8%
Benzalkonium Chloride Plus Chlorhexidine Digluconate
8%
Corymbia
8%
Eucalyptus
8%
Ceftazidime
6%
Monotherapy
6%
Carbapenem Derivative
6%
Piperacillin Plus Tazobactam
6%
Cephalosporin Derivative
6%
Antibiotic Agent
6%
Melaleuca
6%
Chemistry
Tea Tree Oil
58%
Inhibitory Concentration
51%
Chlorhexidine
48%
Imipenem
48%
Tazobactam
48%
Ceftazidime
39%
Ceftolozane
39%
Antimicrobial Agent
37%
Essential Oil
31%
Tobramycin
24%
Antibacterial Agent
19%
Antiseptic
19%
Lactam
19%
Beta Lactam Antibiotic Agent
19%
Aztreonam
18%
Minimum Inhibitory Concentration
18%
Colistin
18%
Benzalkonium Chloride
9%
Carbapenem
9%
Cephalosporin
9%
Piperacillin
9%
Antibiofilm
6%
Dilution
6%